IL1B and acute respiratory distress syndrome: Such ‘treatment’ could increase survival, attenuate lung injuries and reduce leucocyte infiltration and production of IL-1α, IL-1β, IL-6, TNF-α and macrophage inflammatory protein (MIP)-2, 3 days after the induction of ALI in mice [33].